Rambus Buys Lighting and Display Patents from Imagine Designs

Rambus Inc. (NASDAQ:RMBS), one of the world's premier technology licensing companies, today announced it has acquired the lighting and display portfolio of patents and technology from privately held Imagine Designs Inc.

The patented innovations include technology for general lighting, LCD backlighting, and microelectromechanical system (MEMS) displays, expanding the breadth of products in these applications that can be addressed by Rambus. In addition, Imagine Designs' founder and principal inventor Brian Richardson will join Rambus as a technical director in the Lighting and Display Technology business.

'This acquisition complements our portfolio of leading-edge technology, allowing us to provide a wider range of solutions to our customers for their next-generation LED based lighting and display products,' said Jeff Parker, president of Lighting and Display Technology at Rambus. 'With his strong track record of invention, we are very pleased that Brian joins our world-class team of engineers and scientists to continue the development of this breakthrough technology."

Mr. Richardson joins Rambus to continue the development of innovations and solutions for general lighting and displays. In addition, Mr. Pete Pappanastos has joined Rambus as a director of Strategic Development for the Lighting and Display Technology business. Rambus intends to support and further build the customer relationships and momentum that Imagine Designs established in the entertainment, architecture, street light and general lighting markets.

Source: http://www.rambus.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.